Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 447

1.

Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.

Strasfeld L, Weinstock DM.

Expert Rev Anti Infect Ther. 2006 Jun;4(3):457-68. Review.

PMID:
16771622
2.

Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.

McCoy D, Depestel DD, Carver PL.

Pharmacotherapy. 2009 Nov;29(11):1306-25. doi: 10.1592/phco.29.11.1306. Review.

PMID:
19857148
3.

Role of new antifungal agents in prophylaxis of mycoses in high risk patients.

van Burik JA.

Curr Opin Infect Dis. 2005 Dec;18(6):479-83. Review.

PMID:
16258319
4.

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

Ann Intern Med. 2003 May 6;138(9):705-13.

PMID:
12729424
5.

Antifungal agents in hematopoietic stem cell transplantation.

Parameswaran GI, Segal BH, Almyroudis NG.

Curr Pharm Des. 2008;14(20):2011-21. Review.

PMID:
18691111
6.

Patients at high risk of invasive fungal infections: when and how to treat.

Rüping MJ, Vehreschild JJ, Cornely OA.

Drugs. 2008;68(14):1941-62. Review.

PMID:
18778118
7.

A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.

Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.

Bone Marrow Transplant. 2006 Jul;38(2):127-34. Epub 2006 Jun 5.

PMID:
16751782
8.

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.

Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, Paul M.

J Clin Oncol. 2007 Dec 1;25(34):5471-89. Epub 2007 Oct 1. Review.

PMID:
17909198
9.

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR.

Clin Infect Dis. 2007 Feb 1;44(3):402-9. Epub 2007 Jan 2.

PMID:
17205448
10.

Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.

Tamura K, Drew R.

Drugs Today (Barc). 2008 Jul;44(7):515-30. doi: 10.1358/dot.2008.44.7.1230943. Review.

PMID:
18806902
11.

Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.

Wilson DT, Drew RH, Perfect JR.

Mycopathologia. 2009 Dec;168(6):313-27. doi: 10.1007/s11046-009-9193-9. Epub 2009 Mar 24. Review.

PMID:
19308672
12.

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.

Kontoyiannis DP.

Bone Marrow Transplant. 2011 Feb;46(2):165-73. doi: 10.1038/bmt.2010.256. Epub 2010 Nov 1. Review.

PMID:
21042306
13.

Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.

Michallet M, Ito JI.

J Clin Oncol. 2009 Jul 10;27(20):3398-409. doi: 10.1200/JCO.2008.20.1178. Epub 2009 Jun 1. Review.

PMID:
19487382
14.

Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.

Maertens J.

Eur J Haematol. 2007 Apr;78(4):275-82. Epub 2007 Jan 23. Review.

PMID:
17241370
15.

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.

Clin Infect Dis. 2009 Feb 1;48(3):265-73. doi: 10.1086/595846. Erratum in: Clin Infect Dis. 2009 Mar 1;48(5):690.

PMID:
19115967
16.

Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.

Ziakas PD, Kourbeti IS, Mylonakis E.

Clin Ther. 2014 Feb 1;36(2):292-306.e1. doi: 10.1016/j.clinthera.2013.11.010. Epub 2014 Jan 17.

PMID:
24439393
17.

Antifungal treatment strategies in high risk patients.

Rüping MJ, Vehreschild JJ, Cornely OA.

Mycoses. 2008 Sep;51 Suppl 2:46-51. doi: 10.1111/j.1439-0507.2008.01572.x.

PMID:
18721331
18.

Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.

Marr KA.

Curr Opin Infect Dis. 2008 Aug;21(4):409-14. doi: 10.1097/QCO.0b013e328307c7d9. Review.

PMID:
18594294
19.

New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.

Leather HL, Wingard JR.

Blood Rev. 2006 Sep;20(5):267-87. Epub 2006 Jun 14. Review.

PMID:
16781028
20.

Supplemental Content

Support Center